Glucose Control and Genetic Factors in New Colorectal Cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study explores how blood sugar control and genetics relate to colorectal cancer. Researchers will follow newly diagnosed colorectal cancer patients to understand if blood sugar management and family genes play a role in cancer development, which may help improve future prevention and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 20 and 85 years old
- Have a newly diagnosed colorectal cancer (confirmed by biopsy)
- Have never been diagnosed with diabetes
- Not be severely overweight (BMI under 35)
- Be able to read and sign a consent form
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at metabolic biomarkers in blood and tumor tissue to help detect colorectal cancer earlier, predict outcomes, and monitor for recurrence. It includes both people newly diagnosed with colorectal cancer and healthy volunteers for comparison.
This study looks at genetic factors in people recently diagnosed with diabetes to understand what might predict who needs insulin treatment. Researchers will analyze blood samples and medical information to see if genetic testing could help doctors predict your treatment path.
This study looks at how genetic risk information can help decide who needs colorectal cancer screening and when. Researchers want to see if testing for genetic risk factors improves screening decisions for people who haven't had a colonoscopy before.
This study is looking for people newly diagnosed with colorectal cancer or advanced adenoma to help find better ways to detect the disease early using advanced lab tests on blood samples.
This study looks at how diet and gut bacteria affect colon cancer risk in Black and Non-Hispanic White adults aged 45 to 75 who are at higher risk. You would donate mouth and stool samples and complete food recalls.
This study looks at how genetic risk relates to developing type 2 diabetes, using information from a biobank and body measurements like weight. It may help researchers better identify who is at higher risk before diabetes starts.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.